Core Laboratories NV (CLB) revenue breakdown
By segment, Reservoir Description is the largest at 66% of fiscal 2025 revenue; Production Enhancement grew fastest, 3% a year over 4 years.
By product, Service is the largest at 76% of fiscal 2025 revenue, growing 4% a year over 4 years.
Revenue by segment
Fiscal years, as Core Laboratories NV reports them in its 10-K filings; fiscal 2025 total $527M.
| Segments | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|
| Reservoir Description | $314M | $308M | $333M | $346M | $348M | 66% |
| Production Enhancement | $157M | $182M | $176M | $178M | $179M | 34% |
Revenue by product
Fiscal years, as Core Laboratories NV reports them in its 10-K filings; fiscal 2025 total $527M.
| Products | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|
| Service | $344M | $347M | $372M | $388M | $399M | 76% |
| Product | $126M | $143M | $138M | $136M | $127M | 24% |
Revenue by region
Fiscal years, as Core Laboratories NV reports them in its 10-K filings; fiscal 2025 total $527M.
| Regions | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|
| Other Countries | $322M | $323M | $331M | $345M | $351M | 67% |
| United States | $148M | $167M | $179M | $179M | $175M | 33% |
Questions
Where does Core Laboratories NV make its money?
In fiscal 2025, by segment: Reservoir Description $348M, Production Enhancement $179M.
From Core Laboratories NV's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.